John Westwick
6Patents
4h-index
11Co-inventors
50Inventor score
Filing activity: Mar 7, 2003 → Apr 23, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7935493B2 | Protein fragment complementation assays for high-throughput and high-content screening | Emerging Cross-Sectional Technologies | 13 | Active |
| US7062219B2 | Protein fragment complementation assays for high-throughput and high-content screening | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7306914B2 | Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7351729B2 | JNK inhibitors for use in combination therapy for treating or managing proliferative disorders and cancers | Human Necessities | 5 | Expired |
| US7488583B2 | Fragment complementation assays for G-protein-coupled receptors and their signaling pathways | Physics | 2 | Expired |
| US11897929B2 | Compositions and methods for targeted cytokine delivery | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.